Similar articles for PMID: 23114158

Year	Number of Results
1987	1
1995	1
1996	5
1998	2
2000	1
2001	2
2002	3
2003	1
2004	2
2005	2
2006	3
2007	6
2008	3
2009	2
2010	6
2011	6
2012	11
2013	4
2014	3
2015	12
2016	3
2017	6
2018	9
2019	3
2020	3
2021	4
2022	15
2024	1

1

[Research advance of hematopoietic microenvironment for myelodysplastic syndromes].

Fei CM, Chang CK. Fei CM, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1246-50. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 23114158 Review. Chinese.

2

Biology of the bone marrow microenvironment and myelodysplastic syndromes.

Rankin EB, Narla A, Park JK, Lin S, Sakamoto KM. Rankin EB, et al. Mol Genet Metab. 2015 Sep-Oct;116(1-2):24-8. doi: 10.1016/j.ymgme.2015.07.004. Epub 2015 Jul 20. Mol Genet Metab. 2015. PMID: 26210353 Free PMC article. Review.

3

[Bone Marrow Microenvironment and Myelodysplastic Syndromes--Review].

Zhang GC, Wang HQ, Shao ZH. Zhang GC, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):290-4. doi: 10.7534/j.issn.1009-2137.2016.01.056. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 26913439 Review. Chinese.

4

[Research Advances on Pathogenesis of Myelodysplastic Syndrome].

Xu M, Lu JH. Xu M, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Dec;23(6):1800-7. doi: 10.7534/j.issn.1009-2137.2015.06.049. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015. PMID: 26708914 Review. Chinese.

5

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy.

Zahid MF, Patnaik MM, Gangat N, Hashmi SK, Rizzieri DA. Zahid MF, et al. Eur J Haematol. 2016 Oct;97(4):313-20. doi: 10.1111/ejh.12771. Epub 2016 May 31. Eur J Haematol. 2016. PMID: 27147278 Review.

6

Bone marrow niche in the myelodysplastic syndromes.

Cogle CR, Saki N, Khodadi E, Li J, Shahjahani M, Azizidoost S. Cogle CR, et al. Leuk Res. 2015 Oct;39(10):1020-7. doi: 10.1016/j.leukres.2015.06.017. Epub 2015 Jul 14. Leuk Res. 2015. PMID: 26276090 Review.

7

Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.

Tauro S, Hepburn MD, Bowen DT, Pippard MJ. Tauro S, et al. Haematologica. 2001 Oct;86(10):1038-45. Haematologica. 2001. PMID: 11602409

8

The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.

Das M, Chatterjee S, Basak P, Das P, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S. Das M, et al. J Stem Cells. 2010;5(2):49-64. J Stem Cells. 2010. PMID: 22049615

9

The inflammatory microenvironment in MDS.

Yang L, Qian Y, Eksioglu E, Epling-Burnette PK, Wei S. Yang L, et al. Cell Mol Life Sci. 2015 May;72(10):1959-66. doi: 10.1007/s00018-015-1846-x. Epub 2015 Feb 8. Cell Mol Life Sci. 2015. PMID: 25662443 Review.

10

Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.

Aanei CM, Catafal LC. Aanei CM, et al. Cytometry A. 2018 Jul;93(9):916-928. doi: 10.1002/cyto.a.23506. Epub 2018 Sep 13. Cytometry A. 2018. PMID: 30211968 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year